IP Library Granted Patent US 11,833,200
Granted Patent B2
US 11,833,200 · App. 13/497,767 · Granted Dec 5, 2023

Method of preparing plant-derived proteins

Inventors: Louis-Philippe Vezina (Neuville, CA); Manon Couture (St. Augustin De Desmaures, CA); Dany Paquet (St. Jean Chrysostome, CA); Michele Dargis (Quebec, CA); Marc-Andre D'Aoust (Quebec, CA)
Assignee: MEDICAGO INC.
A61K39/145A61K39/12C12N7/00C12N15/8203C12N15/8257C12N15/8258A61K2039/517A61K2039/5258C12N2760/16123C12N2760/16134
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,833,200
App. No.
13/497,767
Granted
Dec 5, 2023
Kind
B2
Abstract

Methods of preparing plant-derived proteins or suprastructure proteins, are provided. The method may comprise obtaining a plant, or plant matter comprising apoplast-localized proteins, or suprastructure proteins, producing a protoplast/spheroplast fraction and apoplast fraction from the plant or plant matter, and recovering the apoplast fraction. The apoplast fraction comprises plant-derived proteins or suprastructure proteins. Alternatively, the proteins, or suprastructure proteins, may be obtained from plant or plant matter comprising plant-derived proteins or suprastructure proteins, by digesting the plant matter using a cell wall degrading enzyme composition to produced a digested fraction. The digested fraction is filtered to produced a filtered fraction, and the plant-derived proteins or suprastructure proteins, are recovered from the filtered fraction.

Claims (17)

1. A method of preparing plant derived antibodies, the method comprising:

a. obtaining a Nicotiana benthamiana plant or plant matter comprising apoplast-localized antibodies, wherein a nucleic acid comprising a nucleotide sequence encoding the antibodies has been introduced into the Nicotiana benthamiana plant in a transient manner, and wherein the Nicotiana benthamiana plant matter consists of plant leaves, leaf pieces, shredded leaves, or a combination thereof;

b. producing a digested fraction, wherein the digested fraction comprises an apoplast fraction, a protoplast fraction and plant debris, by extraction from the plant or plant matter, wherein the extraction consists of an enzymatic extraction, with a cell wall degrading enzyme mixture, wherein the cell wall degrading enzyme mixture comprises one or more than one cellulase and one or more than one pectinase, wherein a concentration of the one or more than one pectinase is about 1% (v/v) and a concentration of the one or more than one cellulase is about 1% (v/v), about 600 mM mannitol, about 75 mM citrate, and a buffer or buffer system which maintains a pH of about 6.9, at room temperature—with agitation for about 16 hours, wherein substantially all of the protoplasts in the protoplast fraction are disrupted protoplasts; and

c. separating the plant debris from the digested fraction using filtration with a mesh size of more than 250 μm, centrifuging at about 5,000 g for about 15 minutes at room temperature to remove organelles, and to produce a supernatant, and recovering the plant-derived antibodies from the supernatant.

2. The method of claim 1 wherein in the step of obtaining (step a), the plant is grown and the plant or plant matter is harvested.

3. The method of claim 1 wherein the nucleic acid encodes a monoclonal antibody, a polyclonal antibody, a single chain monoclonal antibody, a chimeric antibody, a chimeric monoclonal antibody or a chimeric single chain monoclonal antibody.

4. The method of claim 1 further comprising a step of d) purifying the plant derived proteins, or protein suprastructures, from the supernatant.

5. The method of claim 4 , wherein the step of purifying comprises filtering the supernatant using depth filtration to produce a clarified extract, followed by chromatography of the clarified extract using size exclusion chromatography, cation exchange resin or affinity chromatography, or a combination thereof.

6. A method of preparing plant derived antibodies, the method comprising:

a. obtaining a Nicotiana benthamiana plant or plant matter comprising apoplast-localized antibodies, wherein a nucleic acid comprising a nucleotide sequence encoding the antibodies has been introduced into the Nicotiana benthamiana plant in a transient manner, and wherein the Nicotiana benthamiana plant matter consists of plant leaves, leaf pieces, shredded leaves or a combination thereof;

b. digesting the plant matter using a cell wall degrading enzyme mixture comprising one or more than one cellulase and one or more than one pectinase, wherein a concentration of the one or more than one pectinase is about 1% (v/v) and a concentration of the one or more than one cellulase is about 1% (v/v), about 600 mM mannitol, about 75 mM citrate, and a buffer or buffer system which maintains a pH of about 6.9, at room temperature, with agitation for about 16 hours, to produce a digested fraction, the digested fraction comprising an apoplast fraction, a protoplast fraction and plant debris, wherein substantially all of the protoplasts in the protoplast fraction are disrupted protoplasts; and

c. separating the plant debris from the digested fraction using filtration with a mesh size of more than 250 μm, centrifuging at about 5,000 g for about 15 minutes at room temperature to remove organelles, and to produce a supernatant, and recovering the plant-derived antibodies from the supernatant.

7. The method of claim 6 , wherein the nucleic acid encodes a monoclonal antibody, a polyclonal antibody, a single chain monoclonal antibody, a chimeric antibody, a chimeric monoclonal antibody or a chimeric single chain monoclonal antibody.

8. The method of claim 6 , further comprising the step of d) purifying the plant derived proteins or protein suprastructures, from the supernatant.

9. The method of claim 8 , wherein the step of purifying comprises depth filtration of the supernatant to produce a clarified extract, followed by chromatography of the clarified extract using a cation exchange resin, a size exclusion resin, an affinity resin, or a combination thereof.

10. The method of claim 1 , wherein the cell wall degrading enzyme mixture further comprises about 5 mM to about 200 mM EDTA or EGTA.

11. The method of claim 6 , wherein the cell wall degrading enzyme mixture further comprises about 5 mM to about 200 mM EDTA or EGTA.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2024
From: MEDICAGO INC.
To: ARAMIS BIOTECHNOLOGIES INC.
Reel/Frame 069383/0271 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2012
From: VEZINA, LOUIS-PHILIPPE; DARGIS, MICHELE; COUTURE, MANON; PAQUET, DANY; D'AOUST, MARC-ANDRE
To: MEDICAGO INC.
Reel/Frame 027916/0417 →
Continuity (2)
Provisional Application 61244786 · Sep 22, 2009
Related Publication 20130067807A1 · Mar 21, 2013